Cargando…

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides

We investigate the protective effect of combined vaccination based on live attenuated influenza vaccine (LAIV) and group B streptococcus (GBS) recombinant polypeptides against potential pandemic H7N9 influenza infection followed by GBS burden. Mice were intranasally immunized using 107 50% egg infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desheva, Yulia A, Leontieva, Galina F, Kramskaya, Tatiana A, Smolonogina, Tatiana A, Grabovskaya, Kornelia B, Landgraf, Galina O, Karev, Vadim E, Suvorov, Alexander N, Rudenko, Larisa G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462492/ https://www.ncbi.nlm.nih.gov/pubmed/28615930 http://dx.doi.org/10.1177/1178122X17710949

Ejemplares similares

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A., et al.
Publicado: (2016)

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
por: Desheva, Yulia, et al.
Publicado: (2019)

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
por: Desheva, Yulia A., et al.
Publicado: (2019)

Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
por: Kramskaya, T., et al.
Publicado: (2019)

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021)

Development of experimental pneumococcal vaccine for mucosal immunization
por: Gupalova, Tatiana, et al.
Publicado: (2019)

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
por: Desheva, Yulia A, et al.
Publicado: (2015)

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Development of experimental GBS vaccine for mucosal immunization
por: Gupalova, T., et al.
Publicado: (2018)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
por: Desheva, Yulia, et al.
Publicado: (2018)

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
por: Rekstin, Andrey, et al.
Publicado: (2017)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine
por: Matyushenko, Victoria, et al.
Publicado: (2017)

Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice
por: Desheva, Yulia, et al.
Publicado: (2020)

Assessment of trivalent live influenza vaccines in MDCK cell line
por: Landgraf, G., et al.
Publicado: (2021)

Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination
por: Chirkova, Tatiana, et al.
Publicado: (2008)

Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity
por: Desheva, Yulia, et al.
Publicado: (2023)

Corrigendum to “Assessment of trivalent live influenza vaccines in MDCK cell line” [MethodsX 8 (2021) 101442]
por: Landgraf, G., et al.
Publicado: (2021)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

Autoprobiotics as an Approach for Restoration of Personalised Microbiota
por: Suvorov, Alexander, et al.
Publicado: (2018)

B‐ and T‐cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus‐specific memory T‐cells using trogocytosis‐based method
por: Petukhova, Galina, et al.
Publicado: (2011)

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
por: Isakova-Sivak, Irina, et al.
Publicado: (2014)

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)

Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine
por: Rudenko, Larisa, et al.
Publicado: (2014)

Intranasal Administration for Pain: Oxytocin and Other Polypeptides
por: Bharadwaj, Vimala N., et al.
Publicado: (2021)

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
por: Rudenko, Larisa, et al.
Publicado: (2015)

Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses
por: Matyushenko, Victoria, et al.
Publicado: (2020)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)

Smoke-Free Universities Help Students Avoid Establishing Smoking by Means of Facilitating Quitting
por: Andreeva, Tatiana I, et al.
Publicado: (2016)

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination
por: Lumley, S, et al.
Publicado: (2013)

Study of Antibody-Dependent Reactions of Mast Cells In Vitro and in a Model of Severe Influenza Infection in Mice
por: Mamontov, Andrey, et al.
Publicado: (2021)

6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry
por: Gambaryan, Alexandra S, et al.
Publicado: (2008)

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses
por: Shcherbik, Svetlana, et al.
Publicado: (2015)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1s8g1956pa7q4uhdh1eu38a4s8